India's drug regulatory agency has approved new eye drops that can help remove reading glasses in people who have presbyopia. These new eye drops, known as PresVuand manufactured by Mumbai-based ...

据第三期临床实验的两项数据指出，邀请了共750名年龄介乎40至55岁的老花眼患者，进行为期30天测试。一组滴用Vuity眼药水，另一组用其他眼药水 ...

Lenz Therapeutics may be on the verge of FDA approval for a 'best of breed' solution for near vision loss. But the stock is ...

PresVu eye drops are designed to treat presbyopia, a common age-related condition that affects the eye's ability to focus on nearby objects. This condition, which typically begins in the early 40s ...

LENZ Therapeutics is a pre-commercial biopharmaceutical company focused on developing the first and only aceclidine-based eye drop to improve near vision in people with presbyopia. In this China ...

Presbyopia is an age-related refractive condition marked by a gradual decline in near vision, typically emerging between ages ...

The suspension follows allegations of misleading claims regarding the treatment of presbyopia ... including claims that the eye drop could reduce reliance on reading glasses and offer a non ...

(Nasdaq: LENZ or "LENZ” or the "Company”), a pre-commercial stage biopharmaceutical company focused on the development and ...

A live audio webcast of the Piper Sandler Healthcare Conference fireside chat can be accessed here and on the LENZ ...